Company Description
ORPH (OTC: ORPH) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $37.3M.
This page collects what Stock Titan holds for ORPH, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Latest News
ORPH has 7 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 5 with negative movement. Key topics include fda approval, clinical trial. View all ORPH news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ORPH Company Profile & Sector Positioning
ORPH (ORPH) operates in the Biotechnology industry within the broader Healthcare sector.
Investors comparing ORPH often look at related companies in the same sector, including LAVA Therapeutics N.V. (LVTX), Klotho Neurosciences, Inc. (KLTO), Xilio Therapeutics, Inc. (XLO), Mersana Therapeutics Inc (MRSN), and LakeShore Biopharma Co., Ltd (LSB). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ORPH's relative position within its industry.